Stefania Canova

Use of nivolumab in elderly patients with advanced squamous non–small-cell lung cancer: results from the Italian cohort of an expanded access programme

Francesco Grossi, Lucio Crinò, Antonio Logroscino et al. · European Journal of Cancer · 2018 · 111 citations

Medicine, Geriatric Medicine, Oncology +13

Blood cell count indexes as predictors of outcomes in advanced non-small-cell lung cancer patients treated with Nivolumab

Carlo Putzu, Diego Cortinovis, Francesca Colonese et al. · Cancer Immunology Immunotherapy · 2018 · 76 citations · Full text

Medicine, Hematology, Oncology +13

Bevacizumab plus Fotemustine as First-line Treatment in Metastatic Melanoma Patients: Clinical Activity and Modulation of Angiogenesis and Lymphangiogenesis Factors

Michele Del Vecchio, Roberta Mortarini, Stefania Canova et al. · Clinical Cancer Research · 2010 · 58 citations

Pharmacy, Oncology, Pharmacology +17

Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift

Alessandra Fabbri, Mara Cossa, Angelica Sonzogni et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2017 · 37 citations

Medicine, Endocrinology, Oncology +14

Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity

Anna Passarelli, Vittoria Carbone, Sandro Pignata et al. · Gynecologic Oncology · 2024 · 36 citations · Full text

Medicine, Oncology, Pharmacology +15